S1 Episode 2: Biomarkers and Targeted Therapies for Lung Cancer

Drs Jacob Sands and Pasi Jänne discuss the effectiveness of biomarkers and targeted therapies for lung cancer.
Relevant disclosures can be found with the episode show notes on Medscape (www.medscape.c.... The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US health care professionals.
Resources
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma www.nejm.org/d...
The Value of Next-Generation Sequencing in Patients With Non-Small Cell Lung Cancer www.medscape.o...
ctDNA Shows Promise for Assessing Lung Cancer Treatment Response www.medscape.c...
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer www.nejm.org/d...
Structure-Based Classification Predicts Drug Response in EGFR-Mutant NSCLC www.nature.com...
Targeting Uncommon EGFR Mutations in Advanced NSCLC reference.meds...
Afatinib Prescribing Information docs.boehringe...
Amivantamab Prescribing Information www.janssenlab...
Mobocertinib Prescribing Information content.takeda...
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer www.nejm.org/d...
Real-World Incidence and Impact of Pneumonitis in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors: a Multi-institutional Cohort Study jitc.bmj.com/c...